Wednesday, September 23, 2026

Top 5 This Week

Related Posts

Enveda secures $311M to bring more nature-derived AI drugs into clinical trials

The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Popular Articles